162 related articles for article (PubMed ID: 2925248)
1. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes.
Boesman-Finkelstein M; Walton NE; Finkelstein RA
Infect Immun; 1989 Apr; 57(4):1227-34. PubMed ID: 2925248
[TBL] [Abstract][Full Text] [Related]
2. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
3. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae.
Taheri F; Nazarian S; Ahmadi TS; Gargari SLM
Int Immunopharmacol; 2020 Dec; 89(Pt B):107054. PubMed ID: 33065385
[TBL] [Abstract][Full Text] [Related]
5. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin.
Lahiri A; Agarwal RK; Sanyal SC
J Med Microbiol; 1982 Nov; 15(4):429-40. PubMed ID: 6757437
[TBL] [Abstract][Full Text] [Related]
6. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
Jonson G; Osek J; Svennerholm AM; Holmgren J
Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
[TBL] [Abstract][Full Text] [Related]
7. Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae.
Sciortino CV
J Med Microbiol; 1993 Aug; 39(2):135-40. PubMed ID: 8345508
[TBL] [Abstract][Full Text] [Related]
8. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.
Boesman-Finkelstein M; Finkelstein RA
Infect Immun; 1982 Apr; 36(1):221-6. PubMed ID: 7076295
[TBL] [Abstract][Full Text] [Related]
9. Isolation of special antibodies which react only with homologous enterotoxins from Vibrio cholerae and Enterotoxigenic Escherichia coli.
Honda T; Takeda Y; Miwatani T
Infect Immun; 1981 Nov; 34(2):333-6. PubMed ID: 6171516
[TBL] [Abstract][Full Text] [Related]
10. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
Clements JD; Finkelstein RA
Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
Levine MM; Young CR; Black RE; Takeda Y; Finkelstein RA
J Clin Microbiol; 1985 Feb; 21(2):174-9. PubMed ID: 3882744
[TBL] [Abstract][Full Text] [Related]
13. Orally administered bovine colostral anti-cholera toxin antibodies: results of two clinical trials.
McClead RE; Butler T; Rabbani GH
Am J Med; 1988 Dec; 85(6):811-6. PubMed ID: 3057900
[TBL] [Abstract][Full Text] [Related]
14. Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion.
Yoshiyama Y; Brown WR
Immunology; 1987 Aug; 61(4):543-7. PubMed ID: 3443455
[TBL] [Abstract][Full Text] [Related]
15. Comparison of paired whole milk and dried filter paper samples for anti-enterotoxin and anti-rotavirus activities.
Brown SE; Sauer KT; Nations-Shields M; Shields DS; Araujo JG; Guerrant RL
J Clin Microbiol; 1982 Jul; 16(1):103-6. PubMed ID: 6286715
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
17. Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin.
Yamamoto K; Takeda Y; Miwatani T; Craig JP
Infect Immun; 1983 Sep; 41(3):896-901. PubMed ID: 6411622
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
Fernandez-Miyakawa ME; Brero ML; Mateo NA
Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
Clements JD; Finkelstein RA
Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of a Vibrio cholerae 18-kDa antigen in vibrios.
Sciortino CV
FEMS Microbiol Lett; 1993 Jul; 111(1):49-55. PubMed ID: 8359680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
